Home

News

Extreme Networks Ltd v Extreme E Ltd [2024] EWCA Civ 138614 November 2024Ashton Chantrielle appeared before the Court of Appeal for the Applicant/Respondent (“Extreme E”) in this second appeal from the UKIPO relating to Extreme E’s trade mark registration for services in Class 41. One of the core issues on appeal was the interpretation of “booking of seats for shows” in Extreme E’s trade mark and its […]
SkyKick UK Ltd v Sky Ltd [2024] UKSC 3613 November 2024Adrian Speck KC appeared for the successful Appellants (“SkyKick”) in the proceedings issued by the Respondents (“Sky”) alleging infringement of several SKY marks, and passing off, by SkyKick’s use of SKYKICK for email migration and cloud storage services. In this landmark decision, the Supreme Court held that the registration of a trade mark can be […]
Kieran Corrigan v Timol [2024] EWCA Civ 123318 October 2024Jonathan Hill appeared for the Appellant, Kieran Corrigan & Co Limited (“KCL”) in its appeal against the decision of Jonathan Hilliard KC (sitting as a Deputy High Court Judge) (“the Judge”) to dismiss claims for breach of confidence against the Respondent (“Mr. Timol”). The claims related to the alleged misuse by a company of which […]
Sandoz AG v Biogen MA Inc [2024] EWHC 2567 (Pat)11 October 2024Michael Tappin KC appeared for the Claimants (Sandoz) and Justin Turner KC appeared for the Defendant (Biogen). Sandoz sought revocation of Biogen’s patent and an Arrow declaration, while Biogen counterclaimed for infringement. Biogen’s patent in suit, EP 967, related to a method for assessing the risk of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) […]
BioNTech SE v CureVac SE [2024] EWHC 2538 (Pat)8 October 2024Michael Tappin KC and Michael Conway appeared for the successful Claimant (BioNTech) in this action seeking revocation of two of the Defendant’s (CureVac) patents. The patents, EP 668 and EP 755 were divisionals from a common earlier application and their descriptions were materially identical. They claimed artificial mRNA molecules in which the poly(A) tail was […]
Accord Healthcare v Regents of the University of California [2024] EWHC 2524 (Pat)8 October 2024Justin Turner KC appeared for the Claimants and Andrew Lykiardopoulos KC appeared for the Defendants in this action to revoke the patent and invalidate the SPC owned by the First Defendant and exclusively licensed to the Second Defendant. The patent in suit, EP 196, claimed the compound enzalutamide for the treatment of hormone refractory prostate […]
Pfizer v Glaxosmithkline Biologicals [2024] EWHC 2523 (Pat) 7 October 2024Tom Moody-Stuart KC appeared for the Claimant (Pfizer) and Dr Justin Turner KC appeared for the Defendant (GSK) in an action concerning vaccines for respiratory syncytial virus (RSV). The proceedings concerned two GSK patents – EP 258 and EP 710. Both of these related to a vaccine for RSV. Pfizer brought these proceedings in an […]
New Tenant Nicholas Harris2 October 2024Chambers is delighted to welcome Nicholas Harris as its newest tenant, after successfully completing pupillage.  Nicholas is developing a practice across the full breadth of IP law including patents, trade marks, copyright, design rights, confidential information and related contractual and jurisdictional disputes.  His profile can be viewed here.
Motorola Mobility v Ericsson [2024] EWCA Civ 110030 September 2024Michael Tappin KC appeared for the successful defendants (“Ericsson”) on an appeal by the claimants (“Lenovo”) against an order dismissing its application for an interim injunction to restrain Ericsson from doing acts which Lenovo alleged infringed one of its standard-essential patents (“SEPs”) until final judgment in the claim. Lenovo’s application arose out of a wider […]
Legal 500 Bar Awards 2024 – IP Set of the Year30 September 20248 New Square is delighted to announce that it won Intellectual Property Set of the Year at the Legal 500 UK 2024 Bar Awards, which took place at the Park Plaza Westminster Bridge London on 25th September.